5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 3.17▼ | 2.94▲ |
MA10 | N/A | N/A | N/A | 3.05▲ | 2.88▲ |
MA20 | N/A | N/A | N/A | 2.94▲ | 2.66▲ |
MA50 | N/A | N/A | N/A | 2.81▲ | 3.80▼ |
MA100 | N/A | N/A | N/A | 2.54▲ | 13.25▼ |
MA200 | N/A | N/A | N/A | 2.53▲ | 16.39▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.023▲ | 0.268▲ |
RSI | N/A | N/A | N/A | 64.178▲ | 49.314▼ |
STOCH | N/A | N/A | N/A | 74.171 | 65.021 |
WILL %R | N/A | N/A | N/A | -35.938 | -19.492▲ |
CCI | N/A | N/A | N/A | 77.205 | 129.620▲ |
CDL | $AGY.L Doji Candlestick Pattern Detected | Set Alert |
Tuesday, May 07, 2024 06:28 AM
7 May 2024 Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today provided further detail from the positive top line ...
|
Monday, May 06, 2024 04:59 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
|
Monday, May 06, 2024 04:59 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/05/24 | 3.15 | 3.21 | 3.055 | 3.15 | 661,794 |
13/05/24 | 3.15 | 3.25 | 3.00 | 3.15 | 1,359,366 |
10/05/24 | 3.125 | 3.28 | 3.00 | 3.15 | 881,555 |
09/05/24 | 3.075 | 3.38 | 3.02 | 3.125 | 576,496 |
08/05/24 | 3.075 | 3.30 | 2.99 | 3.30 | 319,390 |
07/05/24 | 2.88 | 3.15 | 2.88 | 3.12 | 2,789,795 |
03/05/24 | 2.875 | 3.00 | 2.875 | 2.875 | 315,076 |
02/05/24 | 2.875 | 3.00 | 2.875 | 2.875 | 973,172 |
01/05/24 | 2.95 | 3.00 | 2.74 | 2.875 | 750,470 |
30/04/24 | 2.90 | 3.00 | 2.80 | 2.90 | 781,865 |
|
|
||||
|
|
||||
|
|